NEUROLOGICAL
DISEASES
Your trial CORE-powered
NEUROLOGICAL DISEASES
PSYCHIATRY
RARE NEUROLOGICAL DISEASES
Rare Neurological Diseases
Rare disorders that affect the central nervous system are challenging for both researchers and clinicians. Patients who are affected by
these disorders often have severe and life-shortening disabilities
with few tools to measure their progression or response to
therapeutic interventions.
Like you, we strive to improve patient outcomes. Our dedicated teams work with you no matter the size nor complexity of your rare neurological disorder study. We ensure high-quality data and trial delivery by implementing safe, flexible processes and workstreams.
THE PROOF
50
%
increase in
enrollment
Click each area to learn more
Whether you are planning for decentralized or traditional clinical trials, We deliver across a range of neurology indications, including Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, rare and pediatric epilepsies and more.
With the multitude of challenges facing CNS clinical trials, having a partner who understands neuroradiology, biomarker development, clinical trial design, and novel delivery scenarios is key to helping you optimize your CNS program.
THE PROOF
Connected approach to your CNS clinical trial
neurology clinical trials since 2013
Psychiatry
Trust our extensive experience running psychiatry clinical trials.
Our expertise spans numerous psychiatric indications — including
addiction disorders, ADHD, autism, bipolar disorders, generalized
anxiety and major depressive disorders, as well as PTSD and
schizophrenia.
THE PROOF
Neurological Diseases
Through our CORE-powered approach to cardiovascular development, IQVIA can help you rethink old challenges and surround your trials with a proven suite of capabilities to help you reach milestones faster, deliver programs within budget, and bring game-changing therapies to patients sooner.
RARE NEUROLOGICAL DISEASES
< BACK
< BACK
< BACK
700+
Through our Connected Intelligence approach to CNS clinical research, IQVIA Biotech can surround your trial with a proven suite of capabilities to help you reach milestones faster. Our specialty CNS team has in-depth knowledge of indications, helping you optimize trial design, and capture best practice, and be at the forefront of successful CNS drug development.
psychiatry clinical trials since 2013
350+
CNS clinical trials
rare neurology clinical trials since 2013
100+
Neurological Diseases
Whether you are planning for decentralized or traditional clinical trials, We deliver across a range of neurology indications, including Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, rare and pediatric epilepsies and more.
With the multitude of challenges facing CNS clinical trials, having a partner who understands neuroradiology, biomarker development, clinical trial design, and novel delivery scenarios is key to helping you optimize your CNS program.
THE PROOF
NEUROLOGICAL DISEASES
PSYCHIATRY
RARE NEUROLOGICAL DISEASES
NEUROLOGICAL DISEASES
PSYCHIATRY
RARE NEUROLOGICAL DISEASES
CNS clinical trials
CNS clinical trials
